Gingival crevicular fluid CSF-1 and IL-34 levels in patients with stage III grade C periodontitis and uncontrolled type 2 diabetes mellitus
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Periodontal diseases are inflammatory conditions that alter the host’s response to microbial pathogens. Type 2 diabetes mellitus (T2DM) is a complex disease that affects the incidence and severity of periodontal diseases. This study investigated the gingival crevicular fluid (GCF) levels of colony-stimulating factor-1 (CSF-1) and interleukin-34 (IL-34) in patients with stage III grade C periodontitis (SIII-GC-P) and stage III grade C periodontitis with uncontrolled type 2 diabetes (SIII-GC-PD). Methods: In total, 72 individuals, including 24 periodontally healthy (PH), 24 SIII-GC-P, and 24 SIII-GC-PD patients, were recruited for this study. Periodontitis patients (stage III) had interdental attachment loss (AL) of 5 mm or more, probing depth (PD) of 6 mm or more, radiographic bone loss advancing to the middle or apical part of the root, and tooth loss (<5) due to periodontal disease. Radiographic bone loss in the teeth was also evaluated; grade C periodontitis was defined as a ratio of the percentage of root bone loss to age greater than 1.0. The plaque index (PI), gingival index (GI), presence of bleeding on probing (BOP), PD, and clinical AL were used for clinical periodontal assessments. GCF samples were obtained and analyzed using an enzyme-linked immunosorbent assay. Results: All clinical parameters—PD, AL, GI, BOP, and PI—were significantly higher in the SIII-GC-PD group than in the PH and SIII-GC-P groups for both the full mouth and each sampling site (P<0.05). The total IL-34 and CSF-1 levels were significantly higher in the SIII-GC-PD group than in the PH and SIII-GC-P groups (P<0.05), and there were significant differences between the periodontitis groups (P<0.05). Conclusions: These findings suggest that IL-34 and CSF-1 expression increases in patients with SIII-GC-PD. CSF-1 was associated with the inflammatory status of periodontal tissues and T2DM, while IL-34 was associated only with T2DM.
Abstract
Purpose: Periodontal diseases are inflammatory conditions that alter the host’s response to microbial pathogens. Type 2 diabetes mellitus (T2DM) is a complex disease that affects the incidence and severity of periodontal diseases. This study investigated the gingival crevicular fluid (GCF) levels of colony-stimulating factor-1 (CSF-1) and interleukin-34 (IL-34) in patients with stage III grade C periodontitis (SIII-GC-P) and stage III grade C periodontitis with uncontrolled type 2 diabetes (SIII-GC-PD). Methods: In total, 72 individuals, including 24 periodontally healthy (PH), 24 SIII-GC-P, and 24 SIII-GC-PD patients, were recruited for this study. Periodontitis patients (stage III) had interdental attachment loss (AL) of 5 mm or more, probing depth (PD) of 6 mm or more, radiographic bone loss advancing to the middle or apical part of the root, and tooth loss (<5) due to periodontal disease. Radiographic bone loss in the teeth was also evaluated; grade C periodontitis was defined as a ratio of the percentage of root bone loss to age greater than 1.0. The plaque index (PI), gingival index (GI), presence of bleeding on probing (BOP), PD, and clinical AL were used for clinical periodontal assessments. GCF samples were obtained and analyzed using an enzyme-linked immunosorbent assay. Results: All clinical parameters—PD, AL, GI, BOP, and PI—were significantly higher in the SIII-GC-PD group than in the PH and SIII-GC-P groups for both the full mouth and each sampling site (P<0.05). The total IL-34 and CSF-1 levels were significantly higher in the SIII-GC-PD group than in the PH and SIII-GC-P groups (P<0.05), and there were significant differences between the periodontitis groups (P<0.05). Conclusions: These findings suggest that IL-34 and CSF-1 expression increases in patients with SIII-GC-PD. CSF-1 was associated with the inflammatory status of periodontal tissues and T2DM, while IL-34 was associated only with T2DM.
참고문헌 (40)
- Gerich JE, "Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus", Mayo Clin Proc, 78, pp.447~456 (2003)
- Preshaw PM, "Periodontitis and diabetes", Br Dent J, 227, pp.577~584 (2019)
- Mealey BL, "Diabetes mellitus and periodontal disease", Periodontol 2000, 44, pp.127~153 (2007)
- Nassar H, "Diabetic periodontitis : a model for activated innate immunity and impaired resolution of inflammation", Periodontol 2000, 43, pp.233~244 (2007)
- Pixley FJ, "CSF-1 regulation of the wandering macrophage : complexity in action", Trends Cell Biol, 14, pp.628~638 (2004)
- Guillonneau C, "Immunoregulatory properties of the cytokine IL-34", Cell Mol Life Sci, 74, pp.2569~2586 (2017)
- Chemel M, "Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients", Ann Rheum Dis, 71, pp.150~154 (2012)
- Chang EJ, "IL-34 is associated with obesity, chronic inflammation, and insulin resistance", J Clin Endocrinol Metab, 99, pp.E1263~E1271 (2014)
- Boström EA, "The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation", PLoS One, 8, pp.e81665~ (2013)
- Chapple IL, "Diabetes and periodontal diseases: consensus report of the Joint EFP", AAP Workshop on Periodontitis and Systemic Diseases, 2013, pp.84, S106~S112
- Barros SP, "Gingival crevicular fluid as a source of biomarkers for periodontitis", Periodontol 2000, 70, pp.53~64 (2016)
- Chapple ILC, "Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions", J Clin Periodontol, 45(Suppl 20), pp.S68~S77 (2018)[DOI]
- Papapanou PN, "Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions", J Clin Periodontol, 45(Suppl 20), pp.S162~S170 (2018)
- Tonetti MS, "Staging and grading of periodontitis : Framework and proposal of a new classification and case definition", J Periodontol, 89(Suppl 1), pp.S159~S172 (2018)
- American Diabetes Association, "Diagnosis and classification of diabetes mellitus", Diabetes Care, 33(Suppl 1), pp.S62~S69 (2010)
- Loe H, "Periodontal disease in pregnancy. I. Prevalence and severity", Acta Odontol Scand, 21, pp.533~551 (1963)
- Silness J, "Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition", Acta Odontol Scand, 22, pp.121~135 (1964)
- Ainamo J, "Problems and proposals for recording gingivitis and plaque", Int Dent J, 25, pp.229~235 (1975)
- Ahmad P, "Systemic manifestations of the periodontal disease : a bibliometric review", Molecules, 25, pp.4508~ (2020)
- Ahmad P, "Repercussions of diabetes mellitus on the oral cavity", Eur J Gen Dent, 8, pp.55~62 (2019)
- MacDonald KP, "The colony-stimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion", J Immunol, 175, pp.1399~1405 (2005)
- Nakamichi Y, "IL-34 and CSF-1 : similarities and differences", J Bone Miner Metab, 31, pp.486~495 (2013)
- Taylor JJ, "Gingival crevicular fluid and saliva", Periodontol 2000, 70, pp.7~10 (2016)
- Lira-Junior R, "CSF-1 and IL-34 levels in peri-implant crevicular fluid and saliva from patients having peri-implant diseases", Clin Oral Investig, 24, pp.309~315 (2020)
- Ahmed P, "The effectiveness of photodynamic and antibiotic gel therapy as an adjunct to mechanical debridement in the treatment of peri-implantitis among diabetic patients", Photodiagnosis Photodyn Ther, 32, pp.102077~ (2020)
- Martinez GL, "Salivary colony stimulating factor-1 and ınterleukin-34 in periodontal disease", J Periodontol, 88, pp.e140~e149 (2017)
- Fredman G, "Impaired phagocytosis in localized aggressive periodontitis : rescue by Resolvin E1", PLoS One, 6, pp.e24422~ (2011)
- Alshahrani FA, "Association of self-rated pain with clinical peri-ımplant parameters and cytokine profile in smokers and never smokers with and without peri-ımplantitis", Applied Sciences, 11, pp.5559~ (2021)
- Ma N, "Expression of IL-34 in chronic periapical lesions and its clinical significance", Shanghai Kou Qiang Yi Xue, 25, pp.53~57 (2016)
- Batra P, "Comparative evaluation of gingival crevicular fluid (GCF) levels of Interleukin-34 levels in periodontally healthy and in patients with chronic and aggressive periodontitis- a cross-sectional study", Saudi Dent J, 31, pp.316~321 (2019)
- Guruprasad CN, "Interleukin-34 levels in gingival crevicular fluid and plasma in periodontal health and disease with and without type-2 diabetes mellitus", J Investig Clin Dent, 9, pp.e12317~ (2018)
- Takeda M, "Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients", J Periodontol, 77, pp.15~20 (2006)
- Ge Y, "Biological functions and clinical implications of interleukin-34 in inflammatory diseases", Adv Protein Chem Struct Biol, 119, pp.39~63 (2020)
- Guruprasad CN, "Effect of nonsurgical periodontal therapy on interleukin-34 levels in periodontal health and disease", Indian J Dent Res, 29, pp.280~285 (2018)
- Alresayes S, "Influence of body fat in patients with dental implant rehabilitation treated with adjunctive photodynamic therapy", Photodiagnosis Photodyn Ther, 31, pp.101831~ (2020)
- Gokhale NH, "Resistin levels in gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus", J Periodontol, 85, pp.610~617 (2014)
- Lu HK, "Cross-sectional analysis of different variables of patients with non-insulin dependent diabetes and their periodontal status", Int J Periodontics Restorative Dent, 24, pp.71~79 (2004)
- Genco RJ, "Relationship of stress, distress and inadequate coping behaviors to periodontal disease", J Periodontol, 70, pp.711~723 (1999)
- Curtis MA, "The total protein concentration of gingival crevicular fluid. Variation with sampling time and gingival inflammation", J Clin Periodontol, 15, pp.628~632 (1988)
- Keles Yucel ZP, "Local and systemic levels of aMMP-8 in gingivitis and stage 3 grade C periodontitis", J Periodontal Res, 55, pp.887~894 (2020)